Insider trading · Q3 2026 · CIK 1764013

Immunovant, Inc. (IMVT) insider trading.

Name: Immunovant, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Immunovant, Inc. reported 19 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 15 sales worth $1.1M.

Transactions: 19
Purchases (P): 0
Sales (S): 15
Net shares, P minus S: -28,378
Insiders: 6
Last filed: 2026-09-25

Insiders

Insider	Relationship	Transactions	Sales
Stout Jay S	Officer · Chief Technology Officer	5	5
Pande Atul	Director	4	2
Van Tuyl Christopher	Officer · Chief Legal Officer	3	3
Gloria Melanie	Officer · Chief Operating Officer	3	3
Venker Eric	Director, Officer · Chief Executive Officer	3	1
Girao Tiago	Officer · Chief Financial Officer	1	1

Transactions

19 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-23	Van Tuyl Christopher	S (D)	2,846	$36.36	176,545	Form 4
2026-08-28	Pande Atul	S (D)	1,500	$43.27	116,731	Form 4
2026-08-28	Pande Atul	M (A)	1,500	$8.43	118,231	Form 4
2026-08-20	Gloria Melanie	S (D)	3,056	$44.16	219,301	Form 4
2026-07-24	Pande Atul	M (A)	1,500	$8.43	118,231	Form 4
2026-07-24	Pande Atul	S (D)	1,500	$39.8	116,731	Form 4
2026-07-23	Girao Tiago	S (D)	6,798	$38.69	240,798	Form 4
2026-07-23	Stout Jay S	S (D)	2,857	$38.69	205,341	Form 4
2026-07-08	Stout Jay S	S (D)	1,399	$39.53	208,275	Form 4
2026-07-08	Stout Jay S	S (D)	77	$39.99	208,198	Form 4
2026-07-08	Stout Jay S	S (D)	105	$39.99	209,674	Form 4
2026-07-08	Stout Jay S	S (D)	1,906	$39.53	209,779	Form 4
2026-07-08	Van Tuyl Christopher	S (D)	63	$39.99	179,391	Form 4
2026-07-08	Van Tuyl Christopher	S (D)	1,143	$39.53	179,454	Form 4
2026-07-08	Gloria Melanie	S (D)	106	$39.99	222,357	Form 4
2026-07-08	Gloria Melanie	S (D)	1,930	$39.53	222,463	Form 4
2026-07-02	Venker Eric	S (D)	3,092	$38.48	254,280	Form 4
2026-07-01	Venker Eric	D (D)	86,629	$38.14	257,372	Form 4
2026-07-01	Venker Eric	M (A)	92,188	$14.46	344,001	Form 4

Transaction codes in this quarter

S: 15 M: 3 D: 1

Get IMVT insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1764013&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · IMVT company page · Immunovant, Inc. on SEC.gov

Questions

Are insiders buying or selling Immunovant, Inc. (IMVT)?

In Q3 2026, insiders at Immunovant, Inc. reported 19 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 15 sales worth $1.1M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Immunovant, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/imvt.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.